Effects of Pgp Transporter Inhibition on CNS Biodistribution of Ondansetron in Healthy Volunteers
Latest Information Update: 12 Apr 2022
At a glance
- Drugs Ondansetron (Primary) ; Tariquidar
- Indications Neuropathic pain
- Focus Pharmacokinetics
- 28 Mar 2022 Status changed from active, no longer recruiting to discontinued.
- 04 Jan 2021 Planned End Date changed from 1 Dec 2020 to 30 Nov 2021.
- 05 May 2020 Status changed from recruiting to active, no longer recruiting.